About us Pricing ContactSubscribe

E

Emiel J. Rutgers

The Netherlands Cancer InstituteORCID https://orcid.org/0000-0002-4244-0106

h-index

—

Publications

—

Citations

—

i10-index

—

Impact (2-yr)

—

Top Publications

A Gene-Expression Signature as a Predictor of Survival in Breast Cancer

New England Journal of Medicine20026,503 citations

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

Annals of Oncology20133,672 citations

Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

Annals of Oncology20151,820 citations

Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial

The Lancet Oncology20141,796 citations

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of Oncology20151,618 citations

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

Annals of Oncology20171,245 citations

Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer

JNCI Journal of the National Cancer Institute20061,223 citations

The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1–3 positive lymph nodes in an independent validation study

Breast Cancer Research and Treatment2008297 citations

Emiel J. Rutgers · Scinovex